Biocorp
Develops and manufactures connected drug delivery systems and medical devices for pharma.
ALCOR | PA
Overview
Corporate Details
- ISIN(s):
- FR0012788065
- LEI:
- 969500TKUAME6031UQ32
- Country:
- France
- Address:
- PARC INDUSTRIEL TECH LAVAUR LA BECHADE, 63500 ISSOIRE
- Website:
- https://biocorpsys.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Biocorp is a medical technology company specializing in the design, development, and manufacturing of drug delivery systems and medical devices for the pharmaceutical industry. Established in 2004, its product portfolio includes both traditional delivery components and innovative connected devices, such as the Mallya smart sensor for injection pens, aimed at improving disease management and patient adherence. The company is recognized for its expertise in device connectivity and systems that enhance drug reconstitution. In June 2023, Biocorp was acquired by the global healthcare company Novo Nordisk.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-01-25 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 135.9 KB | ||
| 2024-01-25 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 158.2 KB | ||
| 2023-10-03 10:59 |
Major Shareholding Notification
Franchissement de seuils
|
French | 202.6 KB | ||
| 2023-10-02 17:30 |
Share Issue/Capital Change
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 116.9 KB | ||
| 2023-10-02 14:04 |
Delisting Announcement
Communiqués publiés en période d'offre publique d'acquisition / OPA Autres comm…
|
French | 146.3 KB | ||
| 2023-09-06 11:20 |
M&A Activity
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 136.6 KB | ||
| 2023-09-04 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 306.3 KB | ||
| 2023-09-04 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 325.3 KB | ||
| 2023-08-28 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuil
|
French | 201.1 KB | ||
| 2023-08-28 13:57 |
Major Shareholding Notification
Franchissement de seuils
|
French | 203.1 KB | ||
| 2023-08-07 14:00 |
M&A Activity
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 390.4 KB | ||
| 2023-08-04 18:00 |
M&A Activity
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 160.8 KB | ||
| 2023-08-04 18:00 |
M&A Activity
Inside Information / Operations of the issuer (acquisitions, sales...)
|
English | 165.6 KB | ||
| 2023-08-02 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 140.7 KB | ||
| 2023-07-06 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 140.7 KB |
Automate Your Workflow. Get a real-time feed of all Biocorp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Biocorp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-14 | N/A | Other | Other | 30,000 | 1,050,000.00 EUR |
| 2023-09-14 | N/A | Other | Other | 7,450 | 260,750.00 EUR |
| 2023-09-14 | N/A | Other | Other | 6,000 | 210,000.00 EUR |
| 2023-08-04 | N/A | Other | Sell | 1,998,800 | 69,958,000.00 EUR |
